Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

vTv Therapeutics (VTVT) Other Operating Expenses (2016)

vTv Therapeutics (VTVT) has disclosed Other Operating Expenses for 3 consecutive years, with $529000.0 as the latest value for Q3 2016.

  • Quarterly Other Operating Expenses fell 9.57% to $529000.0 in Q3 2016 from the year-ago period, while the trailing twelve-month figure was $529000.0 through Jun 2017, down 68.25% year-over-year, with the annual reading at $795000.0 for FY2016, 66.13% down from the prior year.
  • Other Operating Expenses hit $529000.0 in Q3 2016 for vTv Therapeutics, up from $72000.0 in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of $815000.0 in Q4 2015 to a low of $72000.0 in Q2 2016.
  • Historically, Other Operating Expenses has averaged $423100.0 across 3 years, with a median of $448000.0 in 2014.
  • Biggest five-year swings in Other Operating Expenses: skyrocketed 178.16% in 2015 and later tumbled 87.05% in 2016.
  • Year by year, Other Operating Expenses stood at $293000.0 in 2014, then surged by 178.16% to $815000.0 in 2015, then plummeted by 35.09% to $529000.0 in 2016.
  • Business Quant data shows Other Operating Expenses for VTVT at $529000.0 in Q3 2016, $72000.0 in Q2 2016, and $194000.0 in Q1 2016.